Encephalopathy syndrome in children with hemato-oncological disorders is not always posterior and reversible

Pediatr Blood Cancer. 2008 Nov;51(5):629-33. doi: 10.1002/pbc.21688.

Abstract

Background: Posterior reversible leukoencephalopathy (PRES) is a clinical-radiological event that can affect children undergoing chemotherapy regimen. Studies have shown that it is not always reversible, in spite of its original definition. We analyzed PRES cases which occurred during the last 10 years at our institute to focus on their clinical, radiological and EEG follow-up.

Procedures: We analyzed 12 cases of PRES in children who underwent intensive chemotherapy regimens, detailing the acute neurological presentation of the syndrome, their neuro-imaging characteristics (MRI) and EEG findings, in both an acute phase and during follow-up.

Results: All patients survived the acute event, showing a clinical recovery of the acute neurological signs in 1-3 days and normalization of the EEG pattern in a period ranging from 1 to 8 months. During long term follow-up, four patients developed either clinical impairment or EEG-MRI anomalies.

Conclusions: We suggest that a long term follow-up is necessary to determine the reversibility of the neurological events. Clinical observation, as well as EEG and MRI should be included in follow-up evaluations.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antineoplastic Agents / therapeutic use
  • Brain Diseases / complications*
  • Brain Diseases / pathology*
  • Brain Diseases / physiopathology*
  • Child
  • Child, Preschool
  • Diffusion Magnetic Resonance Imaging
  • Electroencephalography
  • Female
  • Hematologic Neoplasms / complications*
  • Hematologic Neoplasms / therapy
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Male
  • Syndrome

Substances

  • Antineoplastic Agents